Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
Although biologic therapies have changed the course of rheumatoid arthritis (RA), today’s major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA. Our s...
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Wiley
2014-01-01
|
| Seria: | Mediators of Inflammation |
| Dostęp online: | http://dx.doi.org/10.1155/2014/342524 |